Feedback
Settings

Settings

Goto Application

1. WO2010093992 - ANTI-FUNGAL FORMULATION

PermaLink
Publication Number WO/2010/093992
Publication Date 19.08.2010
International Application No. PCT/US2010/024193
International Filing Date 12.02.2010
IPC
A01N 43/50 2006.01
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
43Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
48having rings with two nitrogen atoms as the only ring hetero atoms
501,3-Diazoles; Hydrogenated 1,3-diazoles
A61K 31/415 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4151,2-Diazoles
CPC
A61K 31/4178
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
41641,3-Diazoles
4178not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K 47/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen, ; e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
A61K 47/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen, ; e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
A61K 47/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen, ; e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61P 17/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61P 31/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
10Antimycotics
Applicants
  • TOPICA PHARMACEUTICALS, INC [US]/[US] (AllExceptUS)
  • VONTZ, Charles, Gregory [US]/[US] (UsOnly)
  • NAKAMURA, Norifumi [JP]/[US] (UsOnly)
  • DE PORCERI-MORTON, Catherine [US]/[US] (UsOnly)
  • HUGHES, Jeff [US]/[US] (UsOnly)
  • SHAH, Bhavesh [US]/[US] (UsOnly)
  • GERTAS, Peter [US]/[US] (UsOnly)
  • KULKARNI, Vitthal [US]/[US] (UsOnly)
Inventors
  • VONTZ, Charles, Gregory
  • NAKAMURA, Norifumi
  • DE PORCERI-MORTON, Catherine
  • HUGHES, Jeff
  • SHAH, Bhavesh
  • GERTAS, Peter
  • KULKARNI, Vitthal
Agents
  • REANEY, Shannon
Priority Data
61/152,65813.02.2009US
61/162,66123.03.2009US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTI-FUNGAL FORMULATION
(FR) FORMULATION ANTIFONGIQUE
Abstract
(EN)
Provided herein are compositions and formulations comprising an antifungal agent. Pharmaceutical compositions comprising Miconazole in an amount effective for the treatment of onychomycosis are provided. Also provided are methods for treating dermatomycoses and onychomycosis using the compositions and formulations.
(FR)
L'invention concerne des compositions et des formulations comprenant un agent antifongique. Elle concerne des compositions pharmaceutiques comprenant du miconazole en une quantité efficace pour le traitement d'onychomycoses. Elle concerne également des procédés de traitement de dermatomycoses et d'onychomycoses employant les compositions et formulations.
Also published as
EP2395839
CN102395274
CA2752557
EP2745692
ES2468540
BRPI1008440
JP2012518009
AR078118
IL214615
Latest bibliographic data on file with the International Bureau
# -